Trial Profile
A Phase IB/IIA, Single-centered Study of the Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasia
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs OXY 111A (Primary)
- Indications Cholangiocarcinoma; Colorectal cancer; Liver cancer; Pancreatic cancer
- Focus Adverse reactions; Proof of concept
- 21 Aug 2015 New trial record